Chloroplasts—the "light power plants" of plant cells—are increasingly the focus of synthetic biology. These organelles house ...

Xylem Inc. stock surges on Q3 2025 growth, margin gains, and a focus on North American smart metering. Click here to read my most recent analysis of XYL.

Construction of a new $95 million Coriell Institute Strategic Innovation Center is underway in Camden. The building is expected to open in early 2028. The location, which was announced in February, ...

LONDON, Oct 15 (Reuters) - German biotech firm Tubulis said on Wednesday it had raised 308 million euros ($358 million) in its biggest financing round to date, contributing to a total of 495 million ...

After years on the sidelines while investors piled into the next big thing in AI or crypto, biotech is back in focus. The question is whether this rally marks a real recovery or just another ...

In recent years, the presence of per- and poly-fluoroalkyl substances (PFAS), commonly known as "forever chemicals," in medical devices has become a growing concern. Used for their durability, these ...

What if you could transform ChatGPT from a conversational tool into a fully interactive platform, capable of running custom apps tailored to your needs? Thanks to OpenAI’s Apps SDK and Model Context ...

Oct 10 (Reuters) - The U.S. Food and Drug Administration approved on Friday labeling changes for the blood cancer therapy of Johnson & Johnson (JNJ.N), opens new tab and its partner Legend Biotech ...

Language-learning app Duolingo has cast Duo — its adorable and plucky owl mascot — as the star of the company’s first-ever anime series, “最後の決戦 (The Final Test).” The company produced the five-episode ...

Evommune, which is developing drugs targeting the sources of chronic inflammatory diseases, filed for an initial public offering. The Palo Alto, Calif., company is seeking a New York Stock Exchange ...